# A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex

> **NCT01285596** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 75 (actual)

## Conditions studied

- Healthy Volunteers
- Pharmacokinetics of Mirabegron

## Interventions

- **DRUG:** Mirabegron

## Key facts

- **NCT ID:** NCT01285596
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285596, "A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01285596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*